Earnings History Data for Astrazeneca PLC (AZN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Astrazeneca PLC

AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		AZN	Astrazeneca PLC	199,960	1.04	1.01	0.87	AstraZeneca beats Q3 estimates, lifts guidance [11/12/2024 5:03 AM]	65.11	0.31 (0.49%)	63.52	-1.27 (-1.96%)	60.47 - 87.68	8,789,715	9,510,000	285,240
AstraZeneca beats Q3 estimates, lifts guidance [11/12/2024 5:03 AM] AstraZeneca to spend $3.5B to expand U.S. operations [11/12/2024 10:39 AM] Merck, AstraZeneca report positive data for Koselugo in adults [11/12/2024 12:53 PM] AstraZeneca, Daiichi file for FDA accelerated approval of Dato-DXd [11/12/2024 1:28 PM] AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance [2024-11-12 02:33AM] AstraZeneca Raises Outlook on Earnings, Sales Beat [2024-11-12 02:27AM] AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on U.S. investments [2024-11-12 02:05AM] Home Depot earnings, YF Invest: What to Watch [Nov-11-24 04:56PM] Earnings To Watch: AstraZeneca PLC (OSTO:AZN) Reports Q3 2024 Result [Nov-11-24 07:03AM]
25-07-2024	PM		AZN	Astrazeneca PLC	245,460	0.99	0.97	1.08	AstraZeneca beats on top-line; raises FY24 outlook [7/25/2024 2:07 AM]	78.56	-1.14 (-1.44%)	76.64	-3.07 (-3.85%)	60.47 - 80.86	7,995,040	3,240,000	420,964
AstraZeneca Q2 2024 Earnings Preview [7/24/2024 1:31 PM] AstraZeneca interim dividend increased by 7c to $1/share [7/25/2024 5:27 AM] AstraZeneca slips despite 2024 guidance raise on medicines demand [7/25/2024 7:38 AM] AstraZeneca beats on top-line; raises FY24 outlook [7/25/2024 2:07 AM]
25-04-2024	PM		AZN	Astrazeneca PLC	219,660	1.03	0.95	0.96	AstraZeneca beats top-line and bottom-line estimates; reaffirms FY24 outlook [4/25/2024 2:24 AM]	75.22	4.02 (5.64%)	74.98	3.78 (5.31%)	60.47 - 76.56	13,020,768	5,930,000	659,560
AstraZeneca rises as oncology business drives Q1 beat [4/25/2024 8:37 AM] AstraZeneca beats top-line and bottom-line estimates; reaffirms FY24 outlook [4/25/2024 2:24 AM] AstraZeneca Q1 2024 Earnings Preview [4/24/2024 12:24 PM] Liquid biopsy firm Angle signs new commercial agreement with AstraZeneca [4/24/2024 3:16 AM]
08-02-2024	PM		AZN	Astrazeneca PLC	103,840	0.73	0.74	0.69	AstraZeneca beats top-line and bottom-line estimates; initiates FY24 outlook [2/8/2024 2:23 AM]	63.54	-3.01 (-4.52%)	62.00	-4.55 (-6.84%)	61.70 - 76.56	25,347,734	5,790,000	1,809,357
AstraZeneca beats top-line and bottom-line estimates; initiates FY24 outlook [2/8/2024 2:23 AM] AstraZeneca Q4 2023 Earnings Preview [2/7/2024 10:39 AM] AstraZeneca tumbles despite Q4 beat [2/8/2024 7:09 AM] Ionis-AstraZeneca amyloid cardiomyopathy candidate gets FDA fast track designation [2/8/2024 8:35 AM]
09-11-2023	PM		AZN	Astrazeneca PLC	98,530	0.87	0.80	0.84	AstraZeneca reports mixed Q3 earnings; raises FY23 outlook [11/9/2023 2:19 AM]	64.11	0.58 (0.91%)	65.34	1.81 (2.85%)	60.96 - 76.56	5,854,376	5,440,000	372,035
AstraZeneca reports mixed Q3 earnings; raises FY23 outlook [11/9/2023 2:19 AM] AstraZeneca Q3 2023 Earnings Preview [11/8/2023 11:40 AM] AstraZeneca lifts forecast after strong Q3, signs $2B deal for obesity drug [11/9/2023 5:26 AM] AstraZeneca succeeds in Phase 3 trial for liver cancer drug combo [11/9/2023 6:54 AM]
28-07-2023	PM		AZN	Astrazeneca PLC	215,050	1.08	0.98	0.86	AstraZeneca beats Q2 top and bottom line estimates; reaffirms FY23 outlook [7/28/2023 2:19 AM]	71.36	3.22 (4.72%)	71.40	3.26 (4.78%)	52.65 - 76.56	6,781,256	6,210,000	189,808
AstraZeneca beats Q2 top and bottom line estimates; reaffirms FY23 outlook [7/28/2023 2:19 AM] AstraZeneca unit in $1B deal with Pfizer for gene therapies [7/28/2023 6:51 AM] AstraZeneca-Ionis deal for eplontersen expands to Latin America [7/28/2023 8:05 AM]
27-04-2023	PM	5:00 AM ET (Apr 27)	AZN	Astrazeneca PLC	234,520	0.96	0.86	0.95	AstraZeneca beats Q1 top and bottom line estimates; reaffirms FY23 outlook [4/27/2023 2:17 AM]	73.87	0.22 (0.30%)	73.56	-0.09 (-0.12%)	52.65 - 76.56	3,149,474	4,590,000	52,339
AstraZeneca beats Q1 top and bottom line estimates; reaffirms FY23 outlook [4/27/2023 2:17 AM] Will AstraZeneca Q1 results bring positive surprise? [4/26/2023 12:42 PM] Merck, AstraZeneca dip as FDA reviews cancer drug ahead of AdCom meeting [4/26/2023 12:34 PM] Novartis' iptacopan improves hemoglobin levels in rare blood disorder trial full data [4/26/2023 7:28 AM] AstraZeneca Q1 sales boosted by cancer drugs amid COVID products wane [4/27/2023 5:13 AM]
09-02-2023	PM	5:00 AM ET (Feb 9)	AZN	Astrazeneca PLC	199,280	0.69	0.68	0.84	AstraZeneca reports mixed Q4 earnings; issues FY23 soft guidance [2/9/2023 2:12 AM]	67.43	3.07 (4.77%)	68.20	3.84 (5.97%)	52.65 - 72.12	7,166,805	5,710,000	362,075
AstraZeneca reports mixed Q4 earnings; issues FY23 soft guidance [2/9/2023 2:12 AM] AstraZeneca trades higher as Q4 revenue sans COVID products grows; sees sales uptick in FY23 [2/9/2023 5:12 AM]
10-11-2022	PM	0:00 AM ET (Nov 10)	AZN	Astrazeneca PLC	190,060	0.84	0.77	0.54	AstraZeneca reports Q3 earnings beat; uplifts FY 2022 guidance underpinned by strong business performance [11/10/2022 2:17 AM]	65.08	4.03 (6.60%)	65.40	4.35 (7.13%)	52.65 - 71.70	9,419,787	5,200,000	1,160,988
AstraZeneca reports Q3 earnings beat; uplifts FY 2022 guidance underpinned by strong business performance [11/10/2022 2:17 AM] AstraZeneca trades higher as Q3 sales boosted by cancer drugs; raises FY22 EPS outlook [11/10/2022 4:58 AM] AstraZeneca cancels plan to file for US approval of COVID vaccine [11/10/2022 6:51 AM] 5 stocks to watch on Thursday: NIO, AstraZeneca and more [11/10/2022 8:05 AM] Viatris wins court decision on AstraZeneca Symbicort patent [11/10/2022 12:58 PM] Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks [Nov-10-22 08:30AM] AstraZeneca Drops Plan to Sell Covid-19 Vaccine in U.S. [Nov-10-22 05:35AM] FTSE 100: AstraZeneca raises profit guidance amid strong demand [Nov-10-22 05:10AM] AstraZeneca drops submission to US regulators for Covid-19 vaccine approval [Nov-10-22 02:51AM] AstraZeneca lifts guidance after forecast-beating profit and sales [Nov-10-22 02:47AM] AstraZeneca tops quarterly estimates buoyed by cancer drugs [Nov-10-22 02:12AM] AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results [Nov-10-22 02:12AM] AstraZeneca raises 2022 earnings outlook after Q3 results beat estimates [Nov-09-22 10:30PM] AstraZeneca Q3 Preview: Can Shares Stay Strong? [Nov-09-22 05:35PM] FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids [Nov-09-22 11:04AM] Is AstraZeneca PLC (AZN) a Solid Long-Term Investment? [Nov-09-22 10:48AM] Why AstraZeneca (AZN) Might Surprise This Earnings Season [Nov-09-22 08:36AM] PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma [Nov-09-22 07:00AM]
29-07-2022	PM		AZN	Astrazeneca PLC	202,210	0.86	0.78	0.45	AstraZeneca Non-GAAP EPS of $1.72 beats by $0.14, revenue of $10.77B beats by $250M [7/29/2022 3:30 AM]	66.23	-0.49 (-0.73%)	66.83	0.11 (0.16%)	53.63 - 71.70	6,224,033	5,170,000	207,546
AstraZeneca Non-GAAP EPS of $1.72 beats by $0.14, revenue of $10.77B beats by $250M [7/29/2022 3:30 AM] AstraZeneca Q2 2022 Earnings Preview [7/28/2022 12:25 PM] AstraZeneca raises FY outlook on back of Evusheld while Q2 sales soars on cancer drugs [7/29/2022 5:19 AM]
29-04-2022	PM	0:00 AM ET (Apr 29)	AZN	Astrazeneca PLC	205,120	0.95	0.84	0.81	AstraZeneca Non-GAAP EPS of $1.89 beats by $0.76, revenue of $11.39B beats by $430M [4/29/2022 2:59 AM]	66.41	-0.81 (-1.21%)	66.14	-1.08 (-1.61%)	50.66 - 71.70	9,360,875	7,120,000	454,259
COVID-portfolio contribution, sales of cancer drugs in focus for AZN's Q1 earnings [4/28/2022 12:45 PM] AstraZeneca Non-GAAP EPS of $1.89 beats by $0.76, revenue of $11.39B beats by $430M [4/29/2022 2:59 AM] AstraZeneca stock falls despite Q1 revenue soars on Farxiga, cancer drugs, COVID shot; maintains outlook [4/29/2022 5:15 AM] Innate Pharma stock rises on upcoming $50M from partner AstraZeneca, as dosing begins in lung cancer study [4/29/2022 6:47 AM] AstraZeneca plans new Alexion HQ, R&D site in Cambridge, Massachusetts [4/29/2022 7:12 AM] COVID-19: Moderna asks FDA to authorize vaccine for young kids, Merck antiviral pill sales top $3B [Apr-28-22 03:33PM] Merck (MRK) Q1 Earnings & Sales Beat, COVID Drug Adds $3.3B [Apr-28-22 11:34AM] Drug/Biotech Stocks Q1 Earnings Due on Apr 29: BMY, ABBV, AZN [Apr-28-22 10:53AM] Should You Buy AstraZeneca (AZN) Ahead of Earnings? [Apr-28-22 09:19AM] ULTOMIRIS® (ravulizumab-cwvz) Approved in the US for Adults with Generalized Myasthenia Gravis [Apr-28-22 07:00AM] AstraZeneca beats Q1 estimates, keeps 2022 forecasts [Apr-29-22 02:11AM] Dettol Maker Reckitt Says Sales Boosted by Inflation: The London Rush [Apr-29-22 02:54AM] Sales of Covid vaccine set to decline as demand wanes, AstraZeneca predicts [Apr-29-22 03:05AM] AstraZeneca COVID vaccine sales top estimates, keeps overall 2022 forecasts [Apr-29-22 02:11AM] AstraZeneca shares fall as it warns of COVID vaccine sales slump [Apr-29-22 04:00AM] AstraZeneca sales beat forecasts on Covid jab demand [Apr-29-22 03:46AM] AstraZeneca Beats Estimates, but Warns Demand for Covid Vaccine Will Fade [Apr-29-22 04:46AM] AstraZeneca says its COVID shot still has role despite global glut [Apr-29-22 02:11AM] AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook [Apr-29-22 06:10AM] AstraZeneca to open R&D center, new Alexion HQ in Kendall Square [Apr-29-22 06:47AM] Pharma Stock Roundup: Q1 Earnings of LLY, MRK & NVS, FDA Updates for AZN & PFE [Apr-29-22 10:32AM] AstraZeneca (AZN) Q1 Earnings and Revenues Beat Estimates [Apr-29-22 03:12PM]
10-02-2022	PM	5:00 AM ET (Feb 10)	AZN	Astrazeneca PLC	175,550	0.84	0.77	0.54	AstraZeneca Non-GAAP EPS of $1.67 beats by $0.68, revenue of $12.01B beats by $950M [2/10/2022 2:15 AM]	58.62	1.42 (2.48%)	58.23	1.03 (1.80%)	46.48 - 64.21	13,506,629	8,370,000	543,928
Will AstraZeneca's Q4 earnings bring positive surprise? [2/9/2022 12:41 PM] AstraZeneca Non-GAAP EPS of $1.67 beats by $0.68, revenue of $12.01B beats by $950M [2/10/2022 2:15 AM] AstraZeneca FY21 revenue rises 41% Y/Y; FY22: growth in Evusheld, decline in Vaxzevria [2/10/2022 5:08 AM] AstraZeneca declares $1.97 dividend [2/10/2022 5:17 AM] Why AstraZeneca (AZN) Might Surprise This Earnings Season [Feb-09-22 08:46AM] COVAX cuts N.Korea's COVID vaccine allotment after no deliveries accepted [Feb-10-22 02:12AM] AstraZeneca notches up £3bn in Covid jab sales in 2021 [Feb-10-22 03:20AM] UPDATE 1-German shares boosted by Siemens; Atos drags down European tech stocks [Feb-10-22 04:31AM] AstraZeneca COVID vaccine pushes sales to $37bn [Feb-10-22 04:53AM] European stocks struggle on mega earnings day as Siemens, AstraZeneca, SocGen and Unilever report [Feb-10-22 04:46AM] AstraZeneca Sees Higher 2022 Sales, But Warns Covid Revenues Set To Decline [Feb-10-22 05:29AM] European stocks mixed as Brussels cuts Eurozone's growth forecast [Feb-10-22 03:49AM] AstraZeneca warns Covid sales will tumble in 2022 after £3bn jab boost in 2021 [Feb-10-22 07:41AM] AstraZeneca Stock Rises Because It Sees More Salesand Raised Its Dividend [Feb-10-22 08:18AM] AstraZeneca buoys FTSE 100 while Unilever slips on margin guidance [Feb-10-22 08:18AM] European stocks mixed as Brussels cuts eurozone's growth forecast [Feb-10-22 03:49AM] Seagen Crumbles With AstraZeneca Expected To Pressure Its New Drug [Feb-10-22 12:01PM] AstraZeneca and mining giants help lift FTSE [Feb-10-22 12:01PM] AstraZeneca (AZN) Q4 Earnings Beat, COVID Vaccine Drives Sales [Feb-10-22 11:15AM] We're Changing Our Strategy on AstraZeneca [Feb-10-22 07:58AM] AstraZeneca ready to tweak Covid vaccine as it finally draws a profit [Feb-10-22 08:18AM] AstraZeneca PLC ADR to Join the NASDAQ-100 Index Beginning February 22, 2022 [Feb-10-22 05:00PM] Novavax COVID-19 vaccine for teens 82% effective [Feb-10-22 04:33PM] How An AstraZeneca Rivalry Led Seagen Stock To Crumble Despite A Sales Beat [Feb-10-22 04:13PM] Shares of Pharmaceutical Giant AstraZeneca Rise on Upbeat 2022 Sales Outlook [Feb-10-22 10:54AM]
12-11-2021	PM	0:00 AM ET (Nov 12)	AZN	Astrazeneca PLC	195,630	0.54	0.63	0.47	AstraZeneca EPS beats by $0.17, beats on revenue; reaffirms earnings guidance for the full year [11/12/2021 3:35 AM]	58.82	-4.10 (-6.52%)	60.28	-2.64 (-4.20%)	46.48 - 64.21	13,451,910	3,620,000	299,045
AstraZeneca will start taking profits from COVID-19 vaccine sales [11/12/2021 6:57 AM] AstraZeneca shares fall after Q3 results, FY forecast [11/12/2021 5:23 AM] AstraZeneca EPS beats by $0.17, beats on revenue; reaffirms earnings guidance for the full year [11/12/2021 3:35 AM] AstraZeneca Q3 2021 Earnings Preview [11/11/2021 4:00 PM] Biden nominates former commissioner Robert Califf to head FDA [11/12/2021 12:45 PM] Valneva (VALN) Stock Rises on Deal With EU for COVID-19 Jab [Nov-11-21 09:47AM] International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2021 [Nov-11-21 08:35AM] UPDATE 1-EU lists rare spinal condition as side-effect of J&J COVID-19 shot [Nov-11-21 07:04AM] Pfizer making 'misleading' claims about vaccine distribution, says Amnesty International [Nov-11-21 06:32AM] AstraZeneca vaccine turns profitable in Q3, drugmaker banking on new orders [Nov-12-21 02:16AM] AstraZeneca eyes Covid-19 vaccine profit as quarterly sales top $1bn - live updates [Nov-11-21 02:14PM] AstraZeneca vaccine turns profitable, drugmaker banking on new orders [Nov-12-21 02:16AM] Covid vaccines help AstraZeneca sales jump 50% in third quarter [Nov-12-21 03:00AM] AstraZeneca to start taking profit on Covid vaccine as pandemic recedes - live updates [Nov-11-21 02:14PM] AstraZeneca to start taking profit from COVID vaccine after $1bn quarterly sales [Nov-12-21 05:17AM] AstraZeneca Says Covid-19 Vaccine Now Profitable. Why the Stock Is Falling. [Nov-12-21 05:29AM] AstraZeneca shares slide as profits fall short - live updates [Nov-11-21 02:14PM] Johnson & Johnson, Toshiba Follow GE With Split Plans. But the Conglomerate Is Far From Dead. [Nov-12-21 06:47AM] AstraZeneca starts to make modest profit from COVID-19 vaccine [Nov-12-21 02:16AM] Petrol price jumps to new record high as cost of living crisis escalates - live updates [Nov-11-21 02:14PM] 5 Stocks To Watch For November 12, 2021 [Nov-12-21 04:57AM] UPDATE 1-GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion [Nov-12-21 08:44AM] AstraZeneca slumps in London as earnings disappoint, vaccine profits modest [Nov-12-21 08:57AM] AstraZeneca Slips on Q3 Miss, Intends to Start Marking up Covid Vaccine Price [Nov-12-21 01:53AM] Pharma Stock Roundup: AZN, BAYRY Q3 Results, PFE COVID Pill's Strong Efficacy [Nov-12-21 07:09AM] AstraZeneca's COVID-19 Vaccine Turns Profitable In Q3; Reaffirms FY21 Guidance [Nov-12-21 06:02AM] Johnson & Johnson and Toshiba Just Followed GEs Lead With Split Plans. Dont Mourn the Conglomerate. [Nov-12-21 10:19AM] AstraZeneca to start making a profit from Covid jab as virus becomes 'endemic' [Nov-12-21 10:02AM] AstraZeneca to start making a profit from Covid jab as virus becomes endemic [Nov-12-21 10:02AM] The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares [Nov-12-21 07:40AM] Biden and Xi to meet virtually, AstraZeneca begins profiting off COVID vaccines, General Mills eyes sale of brands [Nov-12-21 10:45AM] AstraZeneca has decided to make money from the pandemic after all [Nov-12-21 11:36AM] AstraZeneca (AZN) Q3 Earnings Miss, Sales Beat, Stock Down [Nov-12-21 10:00AM] Push to regain lost pandemic ground falters as FTSE falls [Nov-12-21 12:19PM] Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter [Nov-12-21 10:14AM] Coronavirus: Doctor sees beginning of a wave as winter looms [Nov-12-21 01:47PM] Why AstraZeneca Stock Is Sinking Today [Nov-12-21 02:20PM] Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet [Nov-12-21 12:17PM] Best way to minimize COVID-19 risk this holiday season is by getting vaccinated: Doctor [Nov-12-21 05:45PM] Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop [Nov-12-21 03:11PM] Why AstraZeneca Stock Is Down By 6% Today [Nov-12-21 11:51AM]
29-07-2021	PM	2:00 AM ET (Jul 29)	AZN	Astrazeneca PLC	178,020	0.45	0.45	0.48	AstraZeneca EPS misses by $0.02, beats on revenue; [7/29/2021 3:44 AM]	57.63	0.82 (1.44%)	57.97	1.16 (2.04%)	46.48 - 60.93	8,699,981	29,100,000	1,322,314
AstraZeneca Q2 2021 Earnings Preview [7/28/2021 12:03 PM] AstraZeneca EPS misses by $0.02, beats on revenue; [7/29/2021 3:44 AM] AstraZeneca's COVID-19 vaccine sales beats estimate; 2021 outlook raised to reflect Alexion acquisition [7/29/2021 5:39 AM] AstraZeneca is “exploring different options” for COVID-19 vaccine business - Reuters [7/29/2021 9:45 AM] AstraZeneca and J&J are yet to see need for COVID-19 booster shots [7/29/2021 1:14 PM] Hutchison China MediTech Ltd (HCM) Q2 2021 Earnings Call Transcript [Jul-28-21 05:30PM] Covid-19 vaccine booster shots will become a reality: Doctor [Jul-28-21 01:51PM] Ripple effects of the CDC indoor mask guidance [Jul-28-21 01:47PM] No Increased Risk Of Blood Clots After Second Dose Of AstraZeneca's COVID-19 Shot, Study Shows [Jul-28-21 12:19PM] Tiny kingdom of Bhutan vaccinates 90% of adults in a record seven days [Jul-28-21 01:36AM] AstraZeneca vaccine sales jump to $894 million, submission for U.S. approval delayed [Jul-29-21 02:25AM] European markets unphased by Fed comments on tapering stimulus [Jul-29-21 03:45AM] AstraZeneca COVID-19 vaccine sales jump, but U.S. plans delayed [Jul-29-21 02:25AM] AstraZeneca's sales rise as CEO hails transformational Alexion deal [Jul-29-21 04:50AM] AstraZeneca CEO: COVID-19 vaccine may still have a role in U.S. [Jul-29-21 04:34AM] £7bn boost as FTSE firms shower investors with dividends and buybacks [Jul-29-21 05:33AM] AstraZeneca sees surge in Covid vaccine sales as jabs are rolled out globally [Jul-29-21 05:10AM] UPDATE 1-AstraZeneca CEO hopeful COVID-19 vaccine may still have role in U.S. [Jul-29-21 05:56AM] Exclusive-AstraZeneca exploring options for COVID-19 vaccine business, exec says [Jul-29-21 06:27AM] From Airbus to VW: First-half results to watch today [Jul-29-21 06:43AM] AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges [Jul-29-21 02:25AM] AstraZeneca mulls offloading Covid vaccines business [Jul-29-21 07:04AM] Exclusive-AstraZeneca exploring options for COVID-19 vaccine business - executive [Jul-29-21 06:27AM] Sandy Hook families offered a settlement, J&J vaccine production resumes in Baltimore, AstraZeneca loses money on vaccine [Jul-29-21 11:01AM] AstraZeneca Covid Vaccine Sales Surge. The Drugmaker Has a Dilemma. [Jul-29-21 11:18AM] Biden expected to outline requirement for federal workers to get vaccinated or face regular tests in latest push for vaccine program [Jul-29-21 11:14AM] Biden expected to outline requirement for federal workers to get vaccinated or face regular tests in latest push for U.S. vaccine program [Jul-29-21 11:14AM] Sandy Hook families offered $33 million, J&J vaccine production to resume in Baltimore, AstraZeneca loses money on vaccine [Jul-29-21 11:01AM] AstraZeneca (AZN) Q2 Earnings In Line, Vaccine Aids Sales [Jul-29-21 11:31AM] How the EU destroyed AstraZenecas Covid vaccine dream [Jul-29-21 12:15PM] Exclusive - AstraZeneca exploring options for COVID-19 vaccine business - executive [Jul-29-21 06:27AM] We must move towards vaccine mandates to get ahead of Covid-19: Doctor [Jul-29-21 02:06PM] UPDATE 4-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant [Jul-29-21 06:30PM] AstraZeneca may be done with vaccines. Thats sad but not surprising [Jul-29-21 04:30PM] How EU leaders destroyed AstraZenecas Covid vaccine dream [Jul-29-21 12:15PM]
30-04-2021	PM	5:00 AM ET (Apr 30)	AZN	Astrazeneca PLC	137,500	0.81	0.71	0.53	AstraZeneca EPS beats by $0.66, beats on revenue [4/30/2021 4:02 AM]	52.99	1.63 (3.16%)	53.28	1.91 (3.72%)	46.48 - 64.94	13,879,504	11,370,000	599,737
AstraZeneca EPS beats by $0.66, beats on revenue [4/30/2021 4:02 AM] AstraZeneca shares rise 3% on robust Q1 results; COVID-19 vaccine sales of $275M [4/30/2021 5:18 AM] Vaccitech stock sinks after IPO even though firm co-created AstraZeneca COVID-19 vaccine (update) [4/30/2021 12:14 PM] AstraZeneca wins FDA approval for Farxiga in chronic kidney disease [4/30/2021 4:57 PM] Pfizer and AstraZeneca vaccines don’t eliminate post vaccination COVID-19 deaths: New study [4/30/2021 3:35 PM] PRESS DIGEST- Financial Times - April 30 [Apr-29-21 07:42PM] Eaton Vance Worldwide Health Sciences Fund's Top 4 1st-Quarter Trades [Apr-29-21 07:05PM] Moderna ramps up investments to triple vaccine output, eyes boosters [Apr-29-21 04:47PM] NYC reopening timeline is a disastrous issue: Doctor [Apr-29-21 01:51PM] Danish official calls AstraZeneca 'ethical' option for some nations [Apr-29-21 12:36PM] Doctor: Travel ban from India to the U.S. could be 'counterproductive' [Apr-29-21 12:10PM] Should You Buy AstraZeneca (AZN) Ahead of Earnings? [Apr-29-21 08:41AM] AstraZeneca first-quarter COVID-19 vaccine revenue $275 million [Apr-30-21 02:36AM] UPDATE 1-AstraZeneca Q1 COVID-19 vaccine revenue $275 mln [Apr-30-21 02:33AM] AstraZeneca generates $275m from sales of Covid vaccines [Apr-29-21 08:00PM] AstraZeneca profits double at start of year live updates [Apr-29-21 06:44PM] AstraZeneca reveals sales figures for Covid vaccine live updates [Apr-29-21 06:44PM] AstraZeneca revenues beat forecasts despite Covid vaccine drag [Apr-29-21 08:00PM] AstraZeneca reports COVID vaccine sales of $275 million, expects hit to ease [Apr-30-21 02:36AM] AstraZeneca reports COVID vaccine sales of $275 million, expects hit to ease [Apr-30-21 02:31AM] Darktrace soars on stock market debut live updates [Apr-29-21 06:44PM] AstraZeneca delivers $275m in sales from COVID vaccines [Apr-30-21 04:12AM] AstraZeneca reports $275 million sales of COVID shot, expects hit to ease [Apr-30-21 02:31AM] European stocks struggle higher amid earnings and mixed growth, while U.S. futures head south [Apr-30-21 04:51AM] AstraZeneca says U.S. data load for U.S. COVID-19 vaccine approval very big [Apr-30-21 04:38AM] AstraZeneca forecast boosts shares as COVID shot sales hit $275 million [Apr-30-21 02:31AM] UPDATE 1-AstraZeneca's Soriot: we didn't overpromise on COVID-19 vaccine supplies [Apr-30-21 05:42AM] AstraZeneca's Soriot: we didn't overpromise on COVID-19 vaccine supplies [Apr-30-21 05:05AM] AstraZeneca says on track to deliver on COVID shots as sales hit $275 million [Apr-30-21 02:31AM] UPDATE 2-No regrets: AstraZeneca's Soriot defends COVID-19 vaccine supply [Apr-30-21 05:42AM] No regrets: AstraZeneca's Soriot defends COVID-19 vaccine supply [Apr-30-21 05:05AM] AstraZeneca Reveals Covid-19 Vaccine Sales. That Isnt Why the Stock Is Rising. [Apr-30-21 07:04AM] AstraZeneca reveals COVID-19 vaccine sales but that isnt why the stock is rising [Apr-30-21 07:34AM] UPDATE 1-Spain to extend gap between AstraZeneca doses to 16 weeks [Apr-30-21 08:11AM] Pfizer to Export U.S.-Made Vaccine Doses, Report Says [Apr-30-21 08:18AM] AstraZeneca chief hits back at critics over vaccine shortages [Apr-30-21 07:29AM] AstraZeneca Stock Jumps On Quarterly Beat, No Thanks To Its Covid Vaccine [Apr-30-21 09:30AM] AstraZeneca COVID-19 Vaccine Costs Hit Q1 Earnings; Cancer Meds, Emerging Markets Save The Day [Apr-30-21 06:30AM] UPDATE 2-Spain extends AstraZeneca dose gap to 16 weeks, beyond EU approved limit [Apr-30-21 08:11AM] Dow Jones Drops 200 Points As Chevron Stock Slips; Apple Falls But Amazon Soars [Apr-30-21 10:39AM] India sets another COVID case record and Brazils health minister makes plea for vaccines [Apr-30-21 10:47AM] AstraZeneca (AZN) Q1 Earnings Top, COVID-19 Vaccine Adds $275M [Apr-30-21 10:19AM] UPDATE 1-Mexico expects to receive 5 mln more AstraZeneca doses from U.S. [Apr-30-21 11:04AM] European stocks struggle at the end of the month, as growth slows and earnings roll in [Apr-30-21 10:59AM] Why AstraZeneca Stock Is Jumping Today [Apr-30-21 10:55AM] Alexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On Track [Apr-30-21 10:28AM] India sets another COVID case record, and Brazils health minister makes plea for vaccines [Apr-30-21 12:01PM] Pharma Stock Roundup: Big Drugmakers' Q1 Earnings, Resumption of JNJ US COVID-19 Jabs [Apr-30-21 11:24AM] Dow Jones Drops 200 Points As Stock Market Sells Off; Apple Hit With Antitrust Case [Apr-30-21 12:20PM] California has lowest COVID-19 case rate in the U.S.: RPT [Apr-30-21 01:37PM] Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days [Apr-30-21 11:14AM] West Virginia Governor on offering incentives after state hit a wall in vaccinations [Apr-30-21 02:44PM] 'Things are going to get much worse before they get better' in India: Expert [Apr-30-21 03:31PM] FARXIGA Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression With and Without Type 2 Diabetes [Apr-30-21 06:20PM] AstraZeneca Isn't Counting On Its Covid Vaccine Is AZN Stock A Buy? [Apr-30-21 05:10PM] Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg [Apr-30-21 02:35PM] UPDATE 2-In vaccine supply crunch, Mexico angles for 5 million doses from U.S. [Apr-30-21 11:04AM]
11-02-2021	PM	5:25 AM ET (Feb 11)	AZN	Astrazeneca PLC	131,430	0.54	0.53	0.45	AstraZeneca EPS beats by $0.12, beats on revenue [2/11/2021 4:02 AM]	50.03	0.06 (0.12%)	50.37	0.40 (0.80%)	36.15 - 64.94	9,828,022	9,947,850	3,134,335
AstraZeneca EPS beats by $0.12, beats on revenue [2/11/2021 4:02 AM] AstraZeneca’s COVID-19 antibody therapy undergoes NIH-funded study [2/10/2021 1:24 PM] AstraZeneca declares $1.90 dividend [2/11/2021 6:18 AM] AstraZeneca tops Q4 forecast; C19VAZ sales of $2M [2/11/2021 6:43 AM] COVID-19 vaccination to cover 75% of U.S. adults by mid-summer: Morgan Stanley [2/11/2021 12:25 PM] CLASS ACTION UPDATE for PEN, DECN and AZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Feb-11-21 07:53PM] Coronavirus update: AstraZeneca expects Phase 3 results soon; WHO warns against vaccine nationalism [Feb-11-21 12:04PM] U.K. scientist warns new COVID variant will sweep the world, as California confirms two cases of South African strain [Feb-11-21 10:36AM] AstraZeneca Plc to Host Earnings Call [Feb-11-21 09:45AM] AstraZeneca Focuses on Adapting Vaccine for New Covid-19 Strains as Annual Profits Double [Feb-11-21 07:39AM] UPDATE 2-Africa not 'walking away' from AstraZeneca vaccine, CDC says [Feb-11-21 04:31AM] Not perfect, but saves lives, AstraZeneca says as Africa backs COVID-19 shot [Feb-11-21 02:19AM] With all eyes on COVID-19 vaccine, rest of AstraZeneca sees profits rising [Feb-11-21 02:07AM] AstraZeneca aims to accelerate adaptation of vaccine for new Covid variants [Feb-10-21 07:00PM]
05-11-2020	PM	0:00 AM ET (Nov 5)	AZN	Astrazeneca PLC	135,690	0.47	0.49	0.50	AstraZeneca EPS misses by $0.04, misses on revenue [11/5/2020 3:49 AM]	55.16	0.12 (0.22%)	55.16	0.0 (0.00%)	36.15 - 64.94	6,411,396	4,952,981	10,603

30-07-2020	PM	5:25 AM ET (Jul 30)	AZN	Astrazeneca PLC	147,810	0.48	0.44	0.37	AstraZeneca EPS beats by $0.03, beats on revenue [7/30/2020 2:46 AM]	57.72	1.08 (1.90%)	57.09	0.45 (0.79%)	36.15 - 64.94	5,047,049	15,074,815	635,129